Maltese Antibiotic Stewardship Programme in the Community (MASPIC): protocol of a prospective quasiexperimental social marketing intervention

Erika A Saliba-Gustafsson, Michael A Borg, Senia Rosales-Klintz, Anna Nyberg, Cecilia StålsbyLundborg, Erika A Saliba-Gustafsson, Michael A Borg, Senia Rosales-Klintz, Anna Nyberg, Cecilia StålsbyLundborg

Abstract

Introduction: Antibiotic misuse is a key driver of antibiotic resistance. In 2015/2016, Maltese respondents reported the highest proportions of antibiotic consumption in Europe. Since antibiotics are prescription-only medicines in Malta, research on effective strategies targeting general practitioners' (GPs) knowledge and behaviour is needed. Multifaceted behaviour change (BC) interventions are likely to be effective. Social marketing (SM) can provide the tools to promote sustained BC; however, its utilisation in Europe is limited. This paper aims to describe the design and methods of a multifaceted SM intervention aimed at changing Maltese GPs' antibiotic prescribing behaviour for patients with acute respiratory tract infections (aRTIs).

Methods and analysis: This 4-year quasiexperimental intervention study will be carried out in Malta and includes three phases: preintervention, intervention and postintervention. The preintervention phase intends to gain insight into the practices and attitudes of GPs, pharmacists and parents through interviews, focus group discussions and antibiotic prescribing surveillance. A 6-month intervention targeting GPs will be implemented following assessment of their prescribing intention and readiness for BC. The intervention will likely comprise: prescribing guidelines, patient educational materials, delayed antibiotic prescriptions and GP education. Outcomes will be evaluated in the postintervention phase through questionnaires based on the theory of planned behaviour and stages-of-change theory, as well as postintervention surveillance. The primary outcome will be the antibiotic prescribing rate for all patients with aRTIs. Secondary outcomes will include the proportion of diagnosis-specific antibiotic prescription and symptomatic relief medication prescribed, and the change in GPs stage-of-change and their intention to prescribe antibiotics.

Ethics and dissemination: The project received ethical approval from the University of Malta's Research Ethics Committee. Should this intervention successfully decrease antibiotic prescribing, it may be scaled up locally and transferred to similar settings.

Trial registration number: NCT03218930; Pre-results.

Keywords: clinical Audit; public Health; qualitative Research.

Conflict of interest statement

Competing interests: None declared.

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Figures

Figure 1
Figure 1
A BEHAVE-based marketing plan for a social marketing intervention.

References

    1. World Health Organization. Global Action Plan on Antimicrobial Resistance: Draft Resolution with Amendments Resulting from Informal Consultations. Geneva: WHO, 2015.
    1. World Health Organization. Antimicrobial Resistance: Global Report on Surveillance. Geneva: WHO, 2014.
    1. Ventola CL. The antibiotic resistance crisis. Pharm Ther 2015;40:277–83.
    1. Chandy SJ, Naik GS, Balaji V, et al. . High cost burden and health consequences of antibiotic resistance: the price to pay. J Infect Dev Ctries 2014;8:1096–102. 10.3855/jidc.4745
    1. Stålsby Lundborg C, Tamhankar AJ. Understanding and changing human behaviour–antibiotic mainstreaming as an approach to facilitate modification of provider and consumer behaviour. Ups J Med Sci 2014;119:125–33. 10.3109/03009734.2014.905664
    1. World Health Organization. The Evolving Threat of Antimicrobial Resistance: Options for Action. Geneva: WHO, 2012.
    1. Björkman I, Berg J, Röing M, et al. . Perceptions among Swedish hospital physicians on prescribing of antibiotics and antibiotic resistance. Qual Saf Health Care 2010;19:e8 10.1136/qshc.2008.029199
    1. Sahoo KC, Tamhankar AJ, Johansson E, et al. . Antibiotic use, resistance development and environmental factors: a qualitative study among healthcare professionals in Orissa, India. BMC Public Health 2010;10:629 10.1186/1471-2458-10-629
    1. World Health Organization. WHO Global Strategy for Containment of Antimicrobial Resistance. Geneva: WHO, 2001.
    1. Laxminarayan R, Duse A, Wattal C, et al. . Antibiotic resistance-the need for global solutions. Lancet Infect Dis 2013;13:1057–98. 10.1016/S1473-3099(13)70318-9
    1. Morgan DJ, Okeke IN, Laxminarayan R, et al. . Non-prescription antimicrobial use worldwide: a systematic review. Lancet Infect Dis 2011;11:692–701. 10.1016/S1473-3099(11)70054-8
    1. Goossens H, Ferech M, Vander Stichele R, et al. . Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005;365:579–87. 10.1016/S0140-6736(05)70799-6
    1. Mölstad S, Lundborg CS, Karlsson AK, et al. . Antibiotic prescription rates vary markedly between 13 European countries. Scand J Infect Dis 2002;34:366–71. 10.1080/00365540110080034
    1. European Centre for Disease Prevention and Control. Point Prevalence Survey of Healthcare-Associated Infections and Antimicrobial Use in European Acute Care Hospitals. Stockholm: ECDC, 2013.
    1. European Centre for Disease Prevention and Control. Surveillance of Antimicrobial Consumption in Europe 2012. Stockholm: ECDC, 2014.
    1. European Centre for Disease Prevention and Control. European Surveillance of Antimicrobial Consumption Network (ESAC-Net). (accessed 13 Oct 2016).
    1. van der Velden AW, Pijpers EJ, Kuyvenhoven MM, et al. . Effectiveness of physician-targeted interventions to improve antibiotic use for respiratory tract infections. Br J Gen Pract 2012;62:801–7. 10.3399/bjgp12X659268
    1. van der Velden AW, Kuyvenhoven MM, Verheij TJ. Improving antibiotic prescribing quality by an intervention embedded in the primary care practice accreditation: the ARTI4 randomized trial. J Antimicrob Chemother 2016;71:257–63. 10.1093/jac/dkv328
    1. Fernández Urrusuno R, Flores Dorado M, Vilches Arenas A, et al. . Improving the appropriateness of antimicrobial use in primary care after implementation of a local antimicrobial guide in both levels of care. Eur J Clin Pharmacol 2014;70:1011–20. 10.1007/s00228-014-1704-z
    1. Shapiro DJ, Hicks LA, Pavia AT, et al. . Antibiotic prescribing for adults in ambulatory care in the USA, 2007-09. J Antimicrob Chemother 2014;69:234–40. 10.1093/jac/dkt301
    1. Ackerman SL, Gonzales R, Stahl MS, et al. . One size does not fit all: evaluating an intervention to reduce antibiotic prescribing for acute bronchitis. BMC Health Serv Res 2013;13:462 10.1186/1472-6963-13-462
    1. Adriaenssens N, Coenen S, Tonkin-Crine S, et al. . European Surveillance of Antimicrobial Consumption (ESAC): disease-specific quality indicators for outpatient antibiotic prescribing. BMJ Qual Saf 2011;20:764–72. 10.1136/bmjqs.2010.049049
    1. World Health Organization. The World Medicines Situation. Geneva: WHO, 2004.
    1. Zarb P, Borg MA. Consumption of antibiotics within ambulatory care in Malta. Malta Med J 2011;23:13–18.
    1. TNS Opinion & Social. Special Eurobarometer 445: Antimicrobial Resistance. Brussels: European Commission, 2016.
    1. TNS Opinion & Social. Special Eurobarometer 407: Antimicrobial Resistance. Brussels: European Commission, 2013.
    1. TNS Opinion & Social. Special Eurobarometer 338: Antimicrobial Resistance. Brussels: European Commission, 2010.
    1. Earnshaw S, Monnet DL, Duncan B, et al. . 2008 - the first Europe-wide public information campaign on prudent antibiotic use: methods and survey of activities in participating countries. Euro Surveill 2009;14:19280.
    1. Teixeira Rodrigues A, Roque F, Falcão A, et al. . Understanding physician antibiotic prescribing behaviour: a systematic review of qualitative studies. Int J Antimicrob Agents 2013;41:203–12. 10.1016/j.ijantimicag.2012.09.003
    1. Edwards R, Charani E, Sevdalis N, et al. . Optimisation of infection prevention and control in acute health care by use of behaviour change: a systematic review. Lancet Infect Dis 2012;12:318–29. 10.1016/S1473-3099(11)70283-3
    1. Dyar OJ, Beović B, Vlahović-Palčevski V, et al. . How can we improve antibiotic prescribing in primary care? Expert Rev Anti Infect Ther 2016;14:403–13. 10.1586/14787210.2016.1151353
    1. Borg MA. National cultural dimensions as drivers of inappropriate ambulatory care consumption of antibiotics in Europe and their relevance to awareness campaigns. J Antimicrob Chemother 2012;67:763–7. 10.1093/jac/dkr541
    1. Hulscher ME, Grol RP, van der Meer JW. Antibiotic prescribing in hospitals: a social and behavioural scientific approach. Lancet Infect Dis 2010;10:167–75. 10.1016/S1473-3099(10)70027-X
    1. Borg MA. Lowbury Lecture 2013. Cultural determinants of infection control behaviour: understanding drivers and implementing effective change. J Hosp Infect 2014;86:161–8. 10.1016/j.jhin.2013.12.006
    1. Charani E, Castro-Sánchez E, Holmes A. The role of behavior change in antimicrobial stewardship. Infect Dis Clin North Am 2014;28:169–75. 10.1016/j.idc.2014.01.004
    1. Deschepper R, Grigoryan L, Lundborg CS, et al. . Are cultural dimensions relevant for explaining cross-national differences in antibiotic use in Europe? BMC Health Serv Res 2008;8:123 10.1186/1472-6963-8-123
    1. Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process 1991;50:179–211. 10.1016/0749-5978(91)90020-T
    1. Prochaska JO, DiClemente CC, Norcross JC. In search of how people change. Applications to addictive behaviors. Am Psychol 1992;47:1102–14. 10.1037/0003-066X.47.9.1102
    1. Charani E, Edwards R, Sevdalis N, et al. . Behavior change strategies to influence antimicrobial prescribing in acute care: a systematic review. Clin Infect Dis 2011;53:651–62. 10.1093/cid/cir445
    1. Bjerrum L, Munck A, Gahrn-Hansen B, et al. . Health alliance for prudent antibiotic prescribing in patients with respiratory tract infections (HAPPY AUDIT) -impact of a non-randomised multifaceted intervention programme. BMC Fam Pract 2011;12:52 10.1186/1471-2296-12-52
    1. Tonkin-Crine S, Yardley L, Little P. Antibiotic prescribing for acute respiratory tract infections in primary care: a systematic review and meta-ethnography. J Antimicrob Chemother 2011;66:2215–23. 10.1093/jac/dkr279
    1. Huttner B, Goossens H, Verheij T, et al. . Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. Lancet Infect Dis 2010;10:17–31. 10.1016/S1473-3099(09)70305-6
    1. Arnold SR, Straus SE. Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database Syst Rev 2005:CD003539 10.1002/14651858.CD003539.pub2
    1. MacDonald L, Cairns G, Angus K, et al. . Evidence Review: Social Marketing for the Prevention and Control of Communicable Disease. Stockholm: ECDC, 2012.
    1. Smith WA, Strand J. Social Marketing Behavior: a Practical Resource for Social Change Professionals. Washington, DC: Academy for Educational Development, 2008.
    1. National Statistics Office. Malta in Figures 2014. Valletta: Malta: Government Printing Press, 2014.
    1. PricewaterhouseCoopers. Healthcare Delivery in Malta. Malta: PricewaterhouseCoopers, 2012.
    1. Specialist Accreditation Committee Malta. Minimum criteria for entry to the specialist medical registers. Malta: Specialist Accreditation Committee Malta, 2006.
    1. Borg MA, Scicluna EA. Over-the-counter acquisition of antibiotics in the Maltese general population. Int J Antimicrob Agents 2002;20:253–7. 10.1016/S0924-8579(02)00194-2
    1. Edgar T, Boyd SD, Palamé MJ. Sustainability for behaviour change in the fight against antibiotic resistance: a social marketing framework. J Antimicrob Chemother 2009;63:230–7. 10.1093/jac/dkn508
    1. Polit DF, Beck CT. Nursing Research: Generating and Assessing Evidence for Nursing Practice. 8th edition Philadelphia, USA: Lippincott Williams & Wilkins, 2008.
    1. French J, Blair-Stevens C, McVey D, et al. . Social Marketing and Public Health: Theory and Practice. Oxford UK: Oxford University Press, 2010.
    1. World Health Organization. Antimicrobial Resistance: Draft Global Action Plan on Antimicrobial Resistance. Geneva: WHO, 2015.
    1. Bjerrum L, Munck A, Reutskiy A, et al. ; HAPPY AUDIT - Respiratory Tract Infections in General Practice: Total Results 2008/2009 from 6 Countries and 618/511 GPs. Odense, Denmark: Clausen Offset, 2010.
    1. André M, Vernby A, Odenholt I, et al. . Diagnosis-prescribing surveys in 2000, 2002 and 2005 in Swedish general practice: consultations, diagnosis, diagnostics and treatment choices. Scand J Infect Dis 2008;40:648–54. 10.1080/00365540801932439
    1. Francis NA, Butler CC, Hood K, et al. . Effect of using an interactive booklet about childhood respiratory tract infections in primary care consultations on reconsulting and antibiotic prescribing: a cluster randomised controlled trial. BMJ 2009;339:b2885 10.1136/bmj.b2885
    1. Francis NA, Phillips R, Wood F, et al. . Parents’ and clinicians’ views of an interactive booklet about respiratory tract infections in children: a qualitative process evaluation of the EQUIP randomised controlled trial. BMC Fam Pract 2013;14:182 10.1186/1471-2296-14-182
    1. Yardley L, Douglas E, Anthierens S, et al. . Evaluation of a web-based intervention to reduce antibiotic prescribing for LRTI in six European countries: quantitative process analysis of the GRACE/INTRO randomised controlled trial. Implement Sci 2013;8:134 10.1186/1748-5908-8-134
    1. Spurling GK, Del Mar CB, Dooley L, et al. . Delayed antibiotics for respiratory infections. Cochrane Database Syst Rev 2013: CD004417 10.1002/14651858.CD004417.pub4
    1. Francis NA, Gillespie D, Nuttall J, et al. . Delayed antibiotic prescribing and associated antibiotic consumption in adults with acute cough. Br J Gen Pract 2012;62:639–46. 10.3399/bjgp12X654614
    1. Peters S, Rowbotham S, Chisholm A, et al. . Managing self-limiting respiratory tract infections: a qualitative study of the usefulness of the delayed prescribing strategy. Br J Gen Pract 2011;61:579–89. 10.3399/bjgp11X593866
    1. Høye S, Frich J, Lindbœk M. Delayed prescribing for upper respiratory tract infections: a qualitative study of GPs’ views and experiences. Br J Gen Pract 2010;60:907–12. 10.3399/bjgp10X544087
    1. Cals JW, de Bock L, Beckers PJ, et al. . Enhanced communication skills and C-reactive protein point-of-care testing for respiratory tract infection: 3.5-year follow-up of a cluster randomized trial. Ann Fam Med 2013;11:157–64. 10.1370/afm.1477
    1. Regev-Yochay G, Raz M, Dagan R, et al. . Reduction in antibiotic use following a cluster randomized controlled multifaceted intervention: the Israeli judicious antibiotic prescription study. Clin Infect Dis 2011;53:33–41. 10.1093/cid/cir272
    1. Tonkin-Crine S, Anthierens S, Francis NA, et al. . Exploring patients’ views of primary care consultations with contrasting interventions for acute cough: a six-country European qualitative study. NPJ Prim Care Respir Med 2014;24:14026 10.1038/npjpcrm.2014.26
    1. Little P, Stuart B, Francis N, et al. . Effects of internet-based training on antibiotic prescribing rates for acute respiratory-tract infections: a multinational, cluster, randomised, factorial, controlled trial. Lancet 2013;382:1175–82. 10.1016/S0140-6736(13)60994-0
    1. Butler CC, Simpson SA, Dunstan F, et al. . Effectiveness of multifaceted educational programme to reduce antibiotic dispensing in primary care: practice based randomised controlled trial. BMJ 2012;344:d8173 10.1136/bmj.d8173
    1. Bekkers MJ, Simpson SA, Dunstan F, et al. . Enhancing the quality of antibiotic prescribing in primary care: qualitative evaluation of a blended learning intervention. BMC Fam Pract 2010;11:34 10.1186/1471-2296-11-34

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere